TrialBMJ open2017

Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.

Gowrie Balasubramaniam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.